Shigeto Matsushita

30PUBLICATIONS
93CO-AUTHORS
NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jul 07, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|Mar 14, 2026
Immunotherapy for Cutaneous Squamous Cell Carcinoma in Aging Societies: Integrating Immunosenescence and Geriatric Oncology Perspectives.

Shigeto Matsushita, Kazuyasu Fujii, Megumi Aoki

|Jan 08, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol.

Taku Fujimura, Koji Yoshino, Hiroshi Kato

|Jan 05, 2026
Efficacy of adjuvant anti-PD-1 antibody versus observation for resected nail apparatus melanoma.

Takaya Komori, Eiji Nakano, Yukiko Kiniwa

|Dec 31, 2025
Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese Patients.

Azusa Miyashita, Satoshi Fukushima, Koji Yoshino

|Oct 03, 2025
Efficacy and Safety of Helical Tomotherapy Combined With Paclitaxel in Cutaneous Angiosarcoma.

Megumi Aoki, Kazuyasu Fujii, Kentaro Yonekura

Pageof 5

Frequent Collaborators

9 joint publications

Taku Fujimura

8 joint publications

Takeo Maekawa

8 joint publications

Kazuyasu Fujii

7 joint publications

Katsuhiko Nishihara